Clinical trial
A Pilot Study Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia Post-RYGB
NCT02685852 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia Post-RYGB
- Lead sponsor
- University of Minnesota
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 29, 2016
- Completion date
- July 22, 2019
- Enrollment
- 11 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hyperinsulinemic hypoglycemia